BioSyntech Inc (BSYI)
OTHER OTC:BSYI
US Market
Holding BSYI?
Track your performance easily

BioSyntech (BSYI) Stock Price & Analysis

2 Followers

BSYI Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

28.57%0.00%0.00%71.43%
28.57%
Insiders
0.00% Other Institutional Investors
71.43% Public Companies and
Individual Investors

BSYI FAQ

What was BioSyntech Inc’s price range in the past 12 months?
BioSyntech Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
    What is BioSyntech Inc’s market cap?
    Currently, no data Available
    When is BioSyntech Inc’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were BioSyntech Inc’s earnings last quarter?
    Currently, no data Available
    Is BioSyntech Inc overvalued?
    According to Wall Street analysts BioSyntech Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does BioSyntech Inc pay dividends?
      BioSyntech Inc does not currently pay dividends.
      What is BioSyntech Inc’s EPS estimate?
      BioSyntech Inc’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does BioSyntech Inc have?
      BioSyntech Inc has 116,441,000 shares outstanding.
        What happened to BioSyntech Inc’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of BioSyntech Inc?
        Currently, no hedge funds are holding shares in BSYI
        ---

        BioSyntech Stock Smart Score

        Company Description

        BioSyntech Inc

        BioSyntech, Inc. develops biotherapeutic thermogels designed for tissue repair and delivery of therapeutic agents. The company develops products for cartilage repair, chronic wound healing and heel pain relief. It also develops tissue repair products for bone reconstruction and intervertebral disc treatment. The company is also engaged in the development of advanced injectable biomaterials for the delivery of cells, genes and biotherapeutic agents. It also develops instrumentation products. BioSyntech was founded December 14, 1994 and is headquartered in Laval, Canada.
        ---
        Similar Stocks
        Company
        Price & Change
        Follow
        Advaxis
        Cyclacel Pharmaceuticals
        Northwest Biotherapeutics
        Acasti Pharma
        Popular Stocks
        ---
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis